The Chinese biopharmaceutical contract manufacturing market is estimated to be worth USD 2.6 billion in 2030, predicts Roots Analysis
Written by zoye fordThe growing biopharma industry in China has resulted in the creation of lucrative business opportunities for contract service providers; region-specific ..